C.M. Bidwell & Associates’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
SCM
NAMI
TFCM
AIM
AS
AI
C.M. Bidwell & Associates's CGEN Position: Q2 2026 in Review
C.M. Bidwell & Associates held its Compugen (CGEN) position steady in Q2 2026 at 358 shares worth $766. The position accounts for ﹤0.01% of the portfolio, ranked #457.
C.M. Bidwell & Associates first reported a position in CGEN in Q1 2022 and has held it in 17 quarters since. The position peaked at $1K in Q2 2022. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.
- C.M. Bidwell & Associates held 358 shares of Compugen worth $766 as of Q2 2026.
- C.M. Bidwell & Associates left its Compugen share count unchanged in Q2 2026.
- Compugen made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #457 holding.
- C.M. Bidwell & Associates first reported a position in Compugen in Q1 2022 and has held it in 17 quarters since.
- C.M. Bidwell & Associates's Compugen position peaked at $1K in Q2 2022.
- 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.